Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced-stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high-risk patients from the ECHELON-1 study

Martin Hutchings, John Radford, Stephen M. Ansell, Árpád Illés, Anna Sureda, Joseph M. Connors, Alice Sýkorová, Hirohiko Shibayama, Jeremy S. Abramson, Neil S. Chua, Jonathan W. Friedberg, Jan Kořen, Ann Steward LaCasce, Lysiane Molina, Gerald Engley, Keenan Fenton, Hina Jolin, Rachael Liu, Ashish Gautam, Andrea Gallamini

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced-stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high-risk patients from the ECHELON-1 study'. Together they form a unique fingerprint.

Medicine & Life Sciences